Publications
Publications
Show Results For
- All HBS Web
(117,152)
- Faculty Publications (3,557)
- November 2023
- Case
Chai Point
By: Rembrand Koning, Daniel W. Elfenbein and Kanika Jain
Chai Point was an Indian food and beverage company focused on chai. It started in 2010 as a retail store network but soon expanded to corporate offices by developing an IoT-enabled automatic tea and filter coffee machine. By 2023, Chai Point had 170 stores and 5000... View Details
- 2023
- White Paper
Delivering on the Degree: The College to Jobs Playbook
By: David Deming, Joseph B. Fuller, Rachel Lipson, Kerry McKittrick, Ali Epstein and Emma Catalfamo
- 2023
- White Paper
The 2023 American Opportunity Index: Measuring Who Moves Ahead
By: Matthew Sigelman, Joseph B. Fuller, Nik Dawson, Alex Martin and Gad Levanon
- 2023
- White Paper
Unlocking Economic Prosperity: Career Navigation in a Time of Rapid Change
By: Joseph B. Fuller, Kerry McKittrick, Sherry Seibel, Cole Wilson, Vasundhara Dash and Ali Epstein
- 2023
- Working Paper
What Do Impact Investors Do Differently?
In recent years, impact investors – private investors who seek to generate simultaneously financial and social returns – have attracted intense interest and controversy. We analyze a novel, comprehensive data set of impact and traditional investors to assess how the... View Details
- October 2023
- Case
Prime Coalition: Estimating Climate Impact
A case on CRANE, a tool to help investors and green technology companies estimate the future climate impact of new technologies and products, called emissions reduction potential (ERP). The case includes material on CRANE’s methodology for estimating future carbon... View Details
- October 2023 (Revised April 2024)
- Case
Veeva Systems: The Next Frontier
By: Satish Tadikonda and William Marks
Born out of a desire to bring technological advances in enterprise software into the healthcare vertical, Peter Gassner and Matt Wallach founded Veeva to bring life sciences companies into the digital age for data management in both the commercial and R&D sectors. Over... View Details
- October 2023
- Supplement
Hey Jane: Background on Abortion in the U.S.
By: Rembrand Koning, Geraldine Pena-Galea and Sarah Mehta
- October 2023
- Case
Hey Jane: Delivering Abortion Pills to the Doorstep
By: Rembrand Koning, Geraldine Pena-Galea and Sarah Mehta
This case tells the story of Hey Jane, a telehealth clinic founded in 2020 that provides virtual medication abortion services to eligible patients in nine U.S. states. By January 2023, the company had served more than 20,000 patients and raised nearly $10 million in... View Details
- October 2023
- Supplement
Hey Jane: Early Investor Pitch Deck
By: Rembrand Koning
- October 2023 (Revised April 2024)
- Case
TetraScience: Unlocking the Power of Scientific Data
By: Satish Tadikonda and William Marks
After pivoting from a focus on hardware to a focus on scientific data, TetraScience, led by veteran SaaS executive, Patrick Grady and Founder Spin Wang, has embarked on a journey from nearly cash-out to a player in the scientific data management space. This case... View Details
- October 2023 (Revised November 2023)
- Case
Rheaply: Circularity For Every Business
By: Rembrand Koning and Alicia Dadlani
In March 2023, Garry Cooper, cofounder and CEO of Chicago-based Rheaply, needed to demonstrate that Rheaply’s expanded vision could translate into building cash flows and metrics needed to raise a Series B and turn the business into a model for financial and... View Details
- October 2023
- Supplement
Rheaply: Circularity For Every Business Supplement 1
By: Rembrand Koning and Alicia Dadlani
Pitch deck explaining the early vision of the company that was presented by the CEO to potential investors. View Details
- October 2023
- Supplement
Rheaply: Circularity For Every Business Supplement 2
By: Rembrand Koning and Alicia Dadlani
Pitch deck explaining the later vision of the company that was presented by the CEO to potential investors. View Details
- October 2023 (Revised May 2024)
- Case
Thermo Fisher Scientific: Foray into Contract Research
By: Satish Tadikonda, William Marks and Kevin Emancipator
After publicly declaring that they would not enter the contract research organization (CRO) business in 2017, Thermo Fisher purchased Pharmaceutical Product Development (PPD), one of the biggest players in the CRO space, in 2021. Much had changed in the intervening... View Details
- October 2023
- Case
Fixie and Conversational AI Sidekicks
By: Jeffrey J. Bussgang and Carin-Isabel Knoop
In March 2023, Fixie Co-Founder and Chief Architect Matt Welsh and co-founders had the kind of meeting no founders want to have. The president of leading artificial intelligence (AI) research and deployment firm OpenAI, which had catapulted into fame with its ChatGPT... View Details
- October 2023 (Revised July 2024)
- Case
Alnylam: A Loud Silence (A)
By: Satish Tadikonda, William Marks and Shardule Shah
- October 2023 (Revised August 2024)
- Supplement
Alnylam: A Loud Silence (B)
By: Satish Tadikonda, William Marks and Shardule Shah
- October 2023 (Revised June 2024)
- Case
Catalent: Catalyzing the Next Era of Growth
By: Satish Tadikonda, William Marks and Kevin Emancipator
Catalent's newly appointed CEO, Alessandro Maselli, experienced the highs of the pharmaceutical contract development manufacturing (CDMO) space during COVID-19 while helping Moderna and others bring vaccines to market quickly and safely. After rushing to add capacity... View Details
- October 2023
- Case
Vida Health: Transforming Chronic Disease Treatment
By: William Sahlman and Nicole Tempest Keller
San Francisco based Vida Health, founded by Stephanie Tilenius, former vice president of Commerce and Payments at Google, was a B2B digital health startup focused on the treatment of cardiometabolic conditions, such as diabetes and obesity. Its innovative digital... View Details